[1] Oh HS, Rutledge J, Nachun D, et al. Organ aging signatures in the plasma proteome track health and disease[J]. Nature, 2023, 624: 164-172. [2] Manxia A, Gao Y. Urinary biomarkers of brain diseases[J]. Genomics, Proteomics Bioinf, 2015, 13: 345-354. [3] Lyon P, Strippoli V, Fang B, et al. B vitamins and one-carbon metabolism: implications in human health and disease[J]. Nutrients, 2020, 12: 2867. doi: 10.3390/nu12092867. [4] Carling D. AMPK signalling in health and disease[J]. Curr Opin Cell Biol, 2017, 45: 31-37. [5] Mirza AZ, Althagafi II, Shamshad H. Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications[J]. Eur J Med Chem, 2019, 166: 502-513. [6] Schützmann MP, Hasecke F, Bachmann S, et al. Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting[J]. Nat Commun, 2021, 12: 4634. doi: 10.1038/s41467-021-24900-4. [7] Gal H, Majewska J, Krizhanovsky V. The intricate nature of senescence in development and cell plasticity[J]. Semin Cancer Biol, 2022, 87: 214-219. [8] Kamnev A, Lacouture C, Fusaro M, et al. Molecular tuning of actin dynamics in leukocyte migration as revealed by immune-related actinopathies[J]. Front Immunol, 2021, doi: 10.3389/fimmu.2021.750537. [9] Johansson A, Appelqvist H, Nilsson C, et al. Regulation of apoptosis-associated lysosomal membrane permeabiliza-tion[J]. Apoptosis, 2010, 15: 527-540. [10] Yu Y, Kwon K, Tsitrin T, et al. Characterization of early-phase neutrophil extracellular traps in urinary tract infections[J]. PLoS Pathog, 2017, 13: e1006151. doi: 10.1371/journal.ppat.1006151. [11] Zhou Q, Chen L, Tang M, et al. Apelin/APJ system: a novel promising target for anti-aging intervention[J]. Clin Chim Acta, 2018, 487: 233-240. [12] Yeung YT, Guerrero-Castilla A, Cano M, et al. Dysregulation of the Hippo pathway signaling in aging and cancer[J]. Pharmacol Res, 2019, 143: 151-165. |